A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Texas residents who were exposed to greater levels of toxic metals were found to develop markers for type 2 diabetes earlier.

A small new study suggests that time-restricted eating could help improve blood sugar control in some people, thus ...

Recent research has found an association between moderate coffee and caffeine consumption and a lower risk of cardiometabolic ...

Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...

Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

A new study has revealed a startling gap in prenatal care, showing that a commonly used screening method for this condition ...

Neuropathy and retinopathy are positively associated with moderate/severe periodontitis, according to a study published ...